Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ace J Hatch

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cell|December 15, 2010
SnapShot: Inositol phosphatesAce J Hatch, John D York
Advances in Biological Regulation|March 27, 2017
Inositol phosphate multikinase dependent transcriptional controlAce J Hatch, Audrey R Odom, John D York
Cancer Journal (Sudbury, Mass.)|July 30, 2015
Identifying Blood-Based Protein Biomarkers for Antiangiogenic Agents in the Clinic: A Decade of ProgressAce J Hatch, Jeffrey M Clarke, Andrew B Nixon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2014
Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Stephanie M Cushman, Chen Jiang, Ace J Hatch, et al.
Advances in Radiation Oncology|November 2, 2019
Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung CancerMichael N Corradetti, Jordan A Torok, Ace J Hatch, et al.
JAMA Oncology|October 28, 2017
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal CancerJenny F Seligmann, Ace J Hatch, Susan D Richman, et al.
Cancer Medicine|July 29, 2016
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Ace J Hatch, Alexander B Sibley, Mark D Starr, et al.
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
Pharmacogenetics and Genomics|March 20, 2019
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)Federico Innocenti, Chen Jiang, Alexander B Sibley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cell|December 15, 2010
SnapShot: Inositol phosphatesAce J Hatch, John D York
Advances in Biological Regulation|March 27, 2017
Inositol phosphate multikinase dependent transcriptional controlAce J Hatch, Audrey R Odom, John D York
Cancer Journal (Sudbury, Mass.)|July 30, 2015
Identifying Blood-Based Protein Biomarkers for Antiangiogenic Agents in the Clinic: A Decade of ProgressAce J Hatch, Jeffrey M Clarke, Andrew B Nixon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2014
Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Stephanie M Cushman, Chen Jiang, Ace J Hatch, et al.
Advances in Radiation Oncology|November 2, 2019
Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung CancerMichael N Corradetti, Jordan A Torok, Ace J Hatch, et al.
JAMA Oncology|October 28, 2017
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal CancerJenny F Seligmann, Ace J Hatch, Susan D Richman, et al.
Cancer Medicine|July 29, 2016
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)Ace J Hatch, Alexander B Sibley, Mark D Starr, et al.
JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.
Pharmacogenetics and Genomics|March 20, 2019
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)Federico Innocenti, Chen Jiang, Alexander B Sibley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, et al.
Pageof 2